A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer

PurposeColon cancer (CC) is a serious disease burden. The prognosis of patients with CC is different, so looking for effective biomarkers to predict prognosis is vitally important. Ferroptosis is a promising therapeutic and diagnosis strategy in CC. However, the role of ferroptosis in prognosis of C...

Full description

Bibliographic Details
Main Authors: Jianhua Nie, Dan Shan, Shun Li, Shuyuan Zhang, Xiaolin Zi, Fan Xing, Jiaqi Shi, Caiqi Liu, Tianjiao Wang, Xiaoyuan Sun, Qian Zhang, Meng Zhou, Shengnan Luo, Hongxue Meng, Yanqiao Zhang, Tongsen Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.654076/full
id doaj-70b119d37ed24be9ae40362e380718b5
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jianhua Nie
Dan Shan
Shun Li
Shuyuan Zhang
Xiaolin Zi
Fan Xing
Jiaqi Shi
Caiqi Liu
Tianjiao Wang
Xiaoyuan Sun
Qian Zhang
Meng Zhou
Shengnan Luo
Hongxue Meng
Yanqiao Zhang
Tongsen Zheng
Tongsen Zheng
Tongsen Zheng
spellingShingle Jianhua Nie
Dan Shan
Shun Li
Shuyuan Zhang
Xiaolin Zi
Fan Xing
Jiaqi Shi
Caiqi Liu
Tianjiao Wang
Xiaoyuan Sun
Qian Zhang
Meng Zhou
Shengnan Luo
Hongxue Meng
Yanqiao Zhang
Tongsen Zheng
Tongsen Zheng
Tongsen Zheng
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
Frontiers in Oncology
ferroptosis
prognosis
colon cancer
STING
immune status
author_facet Jianhua Nie
Dan Shan
Shun Li
Shuyuan Zhang
Xiaolin Zi
Fan Xing
Jiaqi Shi
Caiqi Liu
Tianjiao Wang
Xiaoyuan Sun
Qian Zhang
Meng Zhou
Shengnan Luo
Hongxue Meng
Yanqiao Zhang
Tongsen Zheng
Tongsen Zheng
Tongsen Zheng
author_sort Jianhua Nie
title A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
title_short A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
title_full A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
title_fullStr A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
title_full_unstemmed A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
title_sort novel ferroptosis related gene signature for prognosis prediction in patients with colon cancer
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-05-01
description PurposeColon cancer (CC) is a serious disease burden. The prognosis of patients with CC is different, so looking for effective biomarkers to predict prognosis is vitally important. Ferroptosis is a promising therapeutic and diagnosis strategy in CC. However, the role of ferroptosis in prognosis of CC has not been studied. The aim of the study is to build a prognosis model related ferroptosis, and provide clues for further therapy of CC.MethodsThe RNA-seq data were from TCGA (training group) and GEO (testing group). The R language and Perl language were used to process and analyze data. LASSO regression analysis was used to build the prognosis model. ssGSEA was used to compare the immune status between two groups. Immunohistochemistry was used to detect expression of AKR1C1 and CARS1 in colon cancer tissues and adjacent tissues.ResultsThe prognosis model consisted of five ferroptosis related genes (AKR1C1, ALOX12, FDFT1, ATP5MC3, and CARS1). The area under curve (AUC) at 1-, 2-, and 3-year were 0.668, 0.678, and 0.686, respectively. The high- and low-risk patients had significant survival probability and could be clearly distinguished by the PCA and t-SNE analysis. The multivariate cox regression analysis also showed the riskscore is an independent prognosis factor. Importantly, we found that the immune status between high- and low-risk patients were different obviously, such as CD8+T cells. And STING, a new promising immune target, was also correlated to our signature genes statistically significantly.ConclusionOur ferroptosis prognosis signature could predict survival of CC patients to a certain degree. And the crosstalk between ferroptosis and immune, especially STING need further studies.
topic ferroptosis
prognosis
colon cancer
STING
immune status
url https://www.frontiersin.org/articles/10.3389/fonc.2021.654076/full
work_keys_str_mv AT jianhuanie anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT danshan anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT shunli anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT shuyuanzhang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT xiaolinzi anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT fanxing anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT jiaqishi anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT caiqiliu anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tianjiaowang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT xiaoyuansun anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT qianzhang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT mengzhou anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT shengnanluo anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT hongxuemeng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT yanqiaozhang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tongsenzheng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tongsenzheng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tongsenzheng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT jianhuanie novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT danshan novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT shunli novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT shuyuanzhang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT xiaolinzi novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT fanxing novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT jiaqishi novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT caiqiliu novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tianjiaowang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT xiaoyuansun novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT qianzhang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT mengzhou novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT shengnanluo novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT hongxuemeng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT yanqiaozhang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tongsenzheng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tongsenzheng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
AT tongsenzheng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer
_version_ 1721452920427249664
spelling doaj-70b119d37ed24be9ae40362e380718b52021-05-11T06:56:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.654076654076A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon CancerJianhua Nie0Dan Shan1Shun Li2Shuyuan Zhang3Xiaolin Zi4Fan Xing5Jiaqi Shi6Caiqi Liu7Tianjiao Wang8Xiaoyuan Sun9Qian Zhang10Meng Zhou11Shengnan Luo12Hongxue Meng13Yanqiao Zhang14Tongsen Zheng15Tongsen Zheng16Tongsen Zheng17Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Radiation Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaThe Seventh Department of the Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Phase 1 Trials Center, Harbin Medical University Cancer Hospital, Harbin, ChinaKey Laboratory of Molecular Oncology, Heilongjiang Cancer Institute, Harbin, ChinaPurposeColon cancer (CC) is a serious disease burden. The prognosis of patients with CC is different, so looking for effective biomarkers to predict prognosis is vitally important. Ferroptosis is a promising therapeutic and diagnosis strategy in CC. However, the role of ferroptosis in prognosis of CC has not been studied. The aim of the study is to build a prognosis model related ferroptosis, and provide clues for further therapy of CC.MethodsThe RNA-seq data were from TCGA (training group) and GEO (testing group). The R language and Perl language were used to process and analyze data. LASSO regression analysis was used to build the prognosis model. ssGSEA was used to compare the immune status between two groups. Immunohistochemistry was used to detect expression of AKR1C1 and CARS1 in colon cancer tissues and adjacent tissues.ResultsThe prognosis model consisted of five ferroptosis related genes (AKR1C1, ALOX12, FDFT1, ATP5MC3, and CARS1). The area under curve (AUC) at 1-, 2-, and 3-year were 0.668, 0.678, and 0.686, respectively. The high- and low-risk patients had significant survival probability and could be clearly distinguished by the PCA and t-SNE analysis. The multivariate cox regression analysis also showed the riskscore is an independent prognosis factor. Importantly, we found that the immune status between high- and low-risk patients were different obviously, such as CD8+T cells. And STING, a new promising immune target, was also correlated to our signature genes statistically significantly.ConclusionOur ferroptosis prognosis signature could predict survival of CC patients to a certain degree. And the crosstalk between ferroptosis and immune, especially STING need further studies.https://www.frontiersin.org/articles/10.3389/fonc.2021.654076/fullferroptosisprognosiscolon cancerSTINGimmune status